EEG parameters correlate to measures of disease severity in patients with Parkinson's Disease. Both EEG slowing and reduced connectivity correlate to non-dopaminergic disease severity. The proposed markers may be useful in the screening process for Deep Brain Stimulation.
Introduction
Parkinson's Disease (PD) is a multisystem neurodegenerative disorder, caused by progressive degeneration of both dopaminergic and non-dopaminergic neurons (Jellinger, 2012) . Dopaminergic neurons account primarily for the characteristic motor symptoms of PD, whilst non-dopaminergic neurons account for non-motor symptoms such as impaired cognition, psychiatric manifestations or sleep disturbances. PD is typically treated with oral dopaminergic medication, which alleviates motor symptoms. However, medication-related motor complications occur in the majority of patients within 10 years of disease (Ahlskog et al., 2001) . Patients refractory to oral treatment may be eligible for Deep Brain Stimulation (DBS), which ameliorates motor complications and improves quality of life (Deuschl et al., 2013) . DBS is particularly effective in patients perceiving substantial motor improvement upon dopaminergic treatment (Moldovan et al., 2015) . However, non-dopaminergic symptoms such as cognitive impairment,
